| Value of inhaled corticosteroid therapy in long-term asthma management. | |
| | |
MedLine Citation:
|
PMID: 20689625 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Asthma, which affects more than 22 million people in the U.S. every year, poses a significant clinical and economic burden to our health care system. Patients, health care practitioners, and payers require a variety of resources to ensure optimal disease management and positive clinical outcomes while also managing costs. In addition, decision makers in health care must determine the most appropriate and cost-efficient therapy or class of agents to achieve asthma control. As such, payers rely on evidence-based medicine, including guidelines to determine the right therapy for the right patient.Inhaled corticosteroid (ICS) therapy plays a critical role in the management of mild-to-moderate persistent asthma. Despite national treatment guidelines that cite ICS therapy as the most effective and safest long-term treatment option for persistent asthma, ICS monotherapy continues to be underused. One retrospective claims study found that 55.2% of children with mild-to-moderate asthma received prescriptions for combination therapy (ICS and long-acting beta-agonists) as initial controller treatment. This practice is contrary to national treatment guidelines, which recommend a step-therapy approach. These prescribing patterns result in higher pharmacy costs, do not always ensure control of symptoms, and sometimes expose patients to potential safety risks.This article addresses the importance of ICS therapy in the treatment of mild-to-moderate asthma, as advocated by the National Asthma Education and Prevention Program (NAEPP) Expert Panel Report 3 guidelines; the role of small airway disease in asthma pathophysiology; and the clinical and economic benefits of ICS therapy. |
| | |
Authors:
|
Donald S Beam |
Related Documents
:
|
22594205 - Management of patients with asthma and allergic rhinitis. 20477125 - Recent advances in the management of occupational asthma. 20592915 - Evolution of asthma concept and effect of current asthma management guidelines. 21836795 - Bioenhancers: revolutionary concept to market. 19552245 - Central venous access devices: review of practice. 21390575 - Metaphysical and value underpinnings of traditional medicine in west africa. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: P & T : a peer-reviewed journal for formulary management Volume: 35 ISSN: 1052-1372 ISO Abbreviation: P T Publication Date: 2010 Jul |
Date Detail:
|
Created Date: 2010-08-06 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9015516 Medline TA: P T Country: United States |
Other Details:
|
Languages: eng Pagination: 377-416 Citation Subset: - |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of decellularization protocol on the mechanical behavior of porcine descending aorta.
Next Document: Topiramate Treatment of Essential Tremor in a Patient with Cognitive Deficits.